11 – 18 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2018
-
Mark
A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition : The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
(
- Contribution to journal › Letter
- 2017
-
Mark
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy.
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations
(
- Contribution to journal › Article
-
Mark
EAU Guidelines on Renal Cell Carcinoma: 2014 Update.
(
- Contribution to journal › Article
-
Mark
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus.
2015) In European Urology(
- Contribution to journal › Scientific review
- « previous
- 1
- 2
- next »